VERAVera Therapeutics, Inc.

HealthcareUSD
$36.81

The financials

Vera Therapeutics, Inc. by the numbers

Vera Therapeutics, Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Operating income−$112M−$80Mn/a
Net income−$109M−$77Mn/a
Diluted EPS−$1.52−$1.20n/a

Biotechnology

Ranks #123 of 145 by Smart Score

Compare peers
RARE+0.48%
Ultragenyx Pharmaceutical Inc.
TARS-4.1%
Tarsus Pharmaceuticals, Inc.
IRON-0.30%
Disc Medicine, Inc.
KLRA-3.3%
Kailera Therapeutics, Inc.
CLDX+0.92%
Celldex Therapeutics, Inc.
ALMS+0.72%
Alumis Inc.